期刊文献+

外周血干细胞移植治疗高危非霍奇金病3例 被引量:1

Treatment with Peripheral Blood Hematopoietic Stem Cell Transplantation for Three Cases of High Risk Non-Hodgkin Lymphoma
下载PDF
导出
摘要 目的探讨外周血造血干细胞移植(PBSCT)治疗高危非霍奇金病患儿(NHL)的方法和疗效。方法对2例高危小无裂型NHL进行自体外周血干细胞移植(APBSCT),1例大细胞型淋巴瘤患儿进行血缘相关PBSCT。2例APBSCT采用环磷酰胺(CTX)3g/m2化疗联合粒细胞集落刺激因子(G-CSF)动员,后予小剂量全身照射(TBI)加抗CD20单抗及不同化疗预处理;1例血缘相关PBSCT患儿予小剂量TBI加化疗预处理,其后回输保存的外周血干细胞。结果3例患儿均移植成功。2例APBSCT移植后1个月复查深部淋巴结消失,随访至移植后22、27个月,造血功能恢复良好,病情处于持续完全缓解状态,仍在继续随访中;1例血缘相关PBSCT移植后5个月死于肺炎。结论PBSCT是治疗儿童高危NHL的有效方法之一,合适的移植时机和预处理至关重要。在早期化疗敏感时行APBSCT,可改善预后。降低放射量,联合强化疗及利妥昔单抗的预处理方案,亦达到预期移植效果。 Objective To explore the treatment methods and effect of peripheral blood hematopoietic stem cell transplantation (PBSCT) for high- risk non - Hodgkin lymphoma(NHL) in children. Methods Two cases with Burkitt's lymphoma received auto -PBSCT( APB- SCT) and 1 case with T cell anaplastic lymphoma received related PBSCT. Two APBSCT patients were mobilized with regimen of cyelophosphamide (3 g/m^2 ) combined with granulocyte colony - stimulating factor ( G - CSF ) and then received the conditioning regimen of low - dose total- body irradiation (TBI) , anti -CD20 -monoclonal antibody (rituximab)and different chemotherapy. The related PBSCT patient received the conditioning regimen of low - dose TBI and chemotherapy. Results The hematopoietic stem cell were all transplanted successfully. The deep lymphoid nodes disappeared in 1 month post - APBSCT. The 2 patients were followed for 22,27 months after APBSCT and the function of hemopoiesis was well. The state of illness retained continuous complete remission. The other patient died of pneumonia 5 months after related PBSCT. Conclusions The treatment of PBSCT is an effective way for high - risk NHL in children. Suitable time of transplantation and good conditioning regimen are very important. APBSCT can improve prognosis if being done in the early stage of being sensitive to chemotherapy. Preconditioning regimen including reduced radiation dose, strong chemotherapy and anti - CD20 - monoclonal antibody has expecting transplantation effect.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2008年第3期182-184,共3页 Journal of Applied Clinical Pediatrics
基金 广东科技计划项目资助(2006B36301003)
关键词 外周血干细胞移植 抗CD20 单克隆抗体 非霍奇金病 儿童 peripheral blood hematopoietic stem cell transplantation anti - CD20 - monoclonal antibody non - Hodgkin lymphoma child
  • 相关文献

参考文献16

  • 1Khouri IF. Reduced - intensity regimens in allogeneic stem - cell translantation for non - Hodgkin lymphoma and chronic lymphocytic leukemia[ J]. Hematology Am Soc Hematol Educ Program,2006:390 -397.
  • 2Sehn LH. Optimal use of prognostic factors in non - hodgkin lymphoma [ J ]. Hematology Am Soc Hematol Educ Program,2006:295 - 302.
  • 3Ramirez VP, Ocqueteau TM, Alvarez ZM, et al. Long term results for intermediate and high grade localized non Hodgkin lymphoma, treated with chemotherapy and radiotherapy [ J ]. Rev Med Chile, 2006, 134 (11) : 1409 -1416.
  • 4孙晓非,甄子俊,刘冬耕,夏忠军,黄慧强,张力,周中梅,李宇红,夏奕,凌家瑜,管忠震.改良BFM-90方案明显改善儿童青少年淋巴母细胞型淋巴瘤的疗效[J].中华肿瘤杂志,2007,29(1):58-61. 被引量:12
  • 5侯盘长,杨学峰,赵跃进.非霍奇金淋巴瘤长期存活的因素分析[J].医药论坛杂志,2007,28(11):21-23. 被引量:4
  • 6陈强,施纯玫,陈玲,范南峰,郑弘宇,杨建伟,刘健.自体外周血干细胞移植支持大剂量化疗治疗淋巴瘤的远期疗效[J].临床肿瘤学杂志,2007,12(1):51-54. 被引量:3
  • 7Bai LY, Chiou TJ, Liu JH. et al. Hematopoietie stem cell transplantation for severe aplastic anemia - experience of an institute in Taiwan [ J ]. Ann Hematol,2004, 83 ( 1 ) : 38 - 43.
  • 8吴晓雄,李红华,达万明,薄剑,王书红,赵瑜,王全顺,张伯龙,于力,韩晓萍.ProMACE/CytaBOM方案治疗难治性或复发性非霍奇金淋巴瘤的疗效观察[J].临床血液学杂志,2003,16(3):105-106. 被引量:5
  • 9van Imhoff GW, van der Holt B, MeKenzie MA, et al. Short intensive sequential therapy followed by autologous stem cell trans plantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma[J]. Leukemia, 2005,19(6) :945 -952.
  • 10Tobinai K. Antibody therapy for malignant lymphoma[ J ]. Intern Med, 2007,46(2) : 99 - 100.

二级参考文献36

  • 1李旭芬,兰琼,黄建瑾.IHOP方案治疗非霍奇金淋巴瘤50例临床疗效评价[J].中国癌症杂志,2004,14(3):291-292. 被引量:11
  • 2Armitage J O, Vose J M, Bierman P J, et al. Salvage therapy for patients with lymphoma. Semin Oncol,1994, 21:82--85.
  • 3Miller T P, Dahlberg S, Weick J K, et al. unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE/CytaBOM:a groupwide south-west oncology group study. J Clin Oncol,1990, 8:1951-1958.
  • 4Cassi E, Butti C, Baldini L, et al. A cooperative study on ProMACE/CytaBOM in aggressive non-Hodgkin's lymphomas. Leukemia and Lymphoma, 1994, 13: 111 --118.
  • 5Longo D L, De Vita V T Jr, Duffey P L, et al. Superiority of ProMACE/CytaBOM over ProMACE-MOPP in the treatment of advanced aggressive lymphoma:results of a prospective randomized trial. J Clin Oncol, 1991,9:25--38.
  • 6Montserrat E, Garcia-Conde J, Vinolas N, et al.CHOP vs ProMACE/CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long term results ofa multicenter randomized trial. Eur J Haematol, 1996,57:377--383.
  • 7Wei-Shu W, Tzeon-Jye C, Jin-Hwang L, et al. ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma:taiwan experience. Jpn J Clin Oncol, 1999,29:33--37.
  • 8Caballero M D, Amigo M L, Hernandez J M, et al.Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas. Ann Hematol,1997, 74:79--82.
  • 9Liu A Y, Robinson R R, Murray E D, et al. Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fe-depon-dent biologic activity[J]. J Immunol, 1987, 139:3521-3526.
  • 10LoBugiio A F, Wheeler R H, Trang J, et al. Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response[J]. Pro Nail Acad Sci USA, 1989, 86:4220-4224.

共引文献40

同被引文献12

  • 1白春梅,杨缇,许莹,张微,刘晓利,朱燕林,陈书长,沈悌.原发肠道非霍奇金淋巴瘤32例临床分析[J].中华肿瘤杂志,2006,28(2):142-144. 被引量:17
  • 2张慧宇,杨志浩,高剑波,杨学华,周志刚,郭华,岳松伟.恶性淋巴瘤累及腹部淋巴结CT表现分析[J].医药论坛杂志,2007,28(2):13-15. 被引量:1
  • 3侯盘长,杨学峰,赵跃进.非霍奇金淋巴瘤长期存活的因素分析[J].医药论坛杂志,2007,28(11):21-23. 被引量:4
  • 4Dawson IM,Cornes JS,Morson BC. Primary malignant lymphoid turnouts of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis[J].Br J Surg, 1961,49 ( 1 ) : 80 - 89.
  • 5王琦璐.恶性淋巴瘤的诊断与治疗[M].北京:北京医科大学协和医科大学联合出版社,1997:159.
  • 6Lupescu IG, Grasu M, Goldis G, et al. Computer tomographic evaluation of digestive tract non - Hodgkin lymphomas [ J ]. J Gastrointestin Liver Dis,2007,16(3) :315 -319.
  • 7Ghai S, Pattison J, Ghai S, et al. Primary gastrointestinal lymphoma: Spectrum of imaging findings with pathologic correlation [ J]. Radiographics, 2007,27(5 ) : 1371 - 1388.
  • 8Hatzaras I, Palesty JA, Abir F, et al. Small - bowel tumors : Epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry [ J ]. Arch Surg,2007,142 ( 3 ) :229 - 235.
  • 9Shukla S, Singh SK, Pujani M. Malticentric malignant gastrointestinal stromal tumor[ J]. Saudi J Gastroenterol,2009,15 ( 1 ) :45 - 48.
  • 10Ott G,Balague -Ponz O,de Leval L,et al. Commentary on the WHO classification of tumors of lymphoid tissues (2008) : Indolent B cell lympbomas[ J]. J Hematop ,2009,2(2) :77 - 81.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部